ASCO’s Oncology Clinical Pathways (OCP) Taskforce recognized New Century Health as developing pathways that are expert driven and promote research and continuous quality improvement, Oncology Clinical Pathways: Charting the Landscape of Pathway Providers (Feb 2018) http://ascopubs.org/doi/10.1200/JOP.17.00033
Atul Dhir, MD, DPhil, New Century Health’s CEO, participated in the inaugural HLTH The Future of Healthcare Conference in Las Vegas on May 8th. In a moderated panel discussion titled “Building Value at Scale”, Dr. Dhir joined leaders from Bright Health, GuideWell and Evolent Health in providing insights about building value-based care models that serve large, diverse, multi-state populations while maintaining quality and cost. More
New Century Health’s Chief Medical Officer, Dr. Andrew Hertler, MD, FACP, participated in a continuing education webinar for the Academy of Managed Care Pharmacy on July 26, 2017. Dr. Hertler’s joint presentation with Ed Li, PharmD, BCOP, MPH, shared insights about the immune-oncology pipeline and managed care considerations.
New Century Health’s Medical Director, Ritwick Panicker, MD, FACP Presented at the Predictive Modelling Summit in Oncology on Friday, June 23rd 2017. Dr. Panicker’s presentation explored how data analytics and clinical decision support tools can be used to prevent avoidable chemotherapy-related hospitalizations. These types of population health analytics and advanced care management approaches ensure that the right patients are getting the best therapies to drive better patient outcomes.
New Century Health Presented at the AMCP Managed Care & Specialty Pharmacy Annual Meeting on March 28, 2017. Andrew Hertler, MD, FACP and Mir Mirnazari, PhD gave a presentation titled “Using Predictive Analytics to Improve Value-Based Cancer Care Delivery”.
Andrew Hertler, New Century Health Chief Medical Officer, to present at the 2nd annual Clinical Pathways Congress in Washington, D.C. September 9, 2017. Dr. Hertler’s presentation will focus on the integration of genomics into clinical pathways.